Two studies published in The Lancet look at AstraZeneca’s GLP-1 pill elecoglipron for weight loss and lowering blood-sugar in adults with and … read more
expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes
Science Media Centre